Status:
COMPLETED
Study of the Implementation of Telehealth-Supported LARC Provision in School-Based Health Centers
Lead Sponsor:
Columbia University
Conditions:
Long Acting Reversible Contraception
Contraception Behavior
Eligibility:
FEMALE
13-22 years
Brief Summary
This is a prospective observational cohort study that will include SBHC patients at the 6 participating SBHCs who receive a reproductive health visit as part of their care in a setting where telehealt...
Detailed Description
Long acting reversible contraceptives (LARCs) are safe and effective for adolescents, but low rates of use among this population and early discontinuation due to method dissatisfaction limits their po...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- an enrolled patient at the participating SBHC
- age 13-22 years
- female
- had a visit at the SBHC during the study period that is coded as a "reproductive health visit" including contraceptive counseling, contraceptive management, and contraceptive method initiation
- Exclusion Criteria (specifically for Aims 2 and 3):
- are younger than age 13 years
- are older than age 22
- are not an enrolled patient of the participating SBHCs
- did not initiate a LARC method
- are a person without a uterus
- are unable to read, speak, and understand either English or Spanish
Exclusion
Key Trial Info
Start Date :
April 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04840836
Start Date
April 20 2021
End Date
December 31 2022
Last Update
June 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Irving Medical Center
New York, New York, United States, 10032